Insider Transactions Reported by 27 Insiders of Tourmaline Bio, Inc.

Symbol
TRML
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 06 Jan 2025

Tourmaline Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NOVARTIS AG 10%+ Owner $1,149,370,768 28 Oct 2025
Suzanne Ildstad Director $75,190,893 12 Jun 2023
Longitude Capital Partners III, LLC 10%+ Owner $54,720,967 11 May 2021
Scott Requadt Former Chief Executive Officer $17,468,591 03 Jul 2023
Clarus Lifesciences III, L.P. 10%+ Owner $2,720,748 11 May 2021
Clarus Defined Exit I, L.P. 10%+ Owner $2,719,148 11 May 2021
Mary Kay Fenton Chief Financial Officer $1,156,237 03 Jul 2023
YUNG H. CHYUNG Chief Medical Officer $965,644 19 Oct 2023
Kevin Bruce Johnson Chief Regulatory Officer $0 28 Oct 2025
Sapna Srivastava Director $0 28 Oct 2025
AARON KANTOFF Director $0 28 Oct 2025
Sandeep Chidambar Kulkarni CEO, Director $0 28 Oct 2025
Parvinder Thiara Director $0 28 Oct 2025
Susan Dana Jones Chief Technology Officer $0 28 Oct 2025
W. BRADFORD MIDDLEKAUFF CBO, GC and Secretary $0 28 Oct 2025
MARK MCDADE Director $0 28 Oct 2025
Caley Castelein Director $0 28 Oct 2025
Ryan F. Robinson Cfo $0 28 Oct 2025
Gaurav Shah Director 13 Jun 2023
Sandip Agarwala Director 13 Jun 2023
Michael Zdanowski Chief Technology Officer 01 Feb 2023
Nancy Krieger Chief Medical Officer 01 Feb 2023
GEOFFREY MACKAY Director 13 Jun 2023
Karen L. Smith Director 13 Jun 2023
Francois Nader Director 13 Jun 2023
Cariad Chester Director 19 Oct 2023
CLAY B. SIEGALL Director 28 Oct 2025

Recent Insider Transactions by Companies or Individuals for Tourmaline Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.